Putting the patient’s voice at the venter: Tracking the impact of botulinum neurotoxin therapy for movement disorders using patient-reported outcomes
Objective: To investigate how patient reported outcomes (PROs) perform to document the effects of a botulinum neurotoxin (BONT) treatment of movement disorders in the clinical…Quantitative gait analysis to evaluate changes in gait pattern after Botulinum toxin A injection by hemiparesis
Objective: This retrospective study aimed to assess the effect of Botulinum toxin A (BoNT-A) injections in the lower limbs of hemiparetic patients on gait parameters,…Safety of incobotulinumtoxinA in pediatrics: A pooled analysis
Objective: To present analyses of pooled data on the safety of incobotulinumtoxinA (INCO) in pediatrics Background: BotulinumtoxinA (BoNT-A) is used to treat several conditions affecting…Pain and Disability Outcomes in Hemiparetic Patients Naive to Botulinum Toxins With Upper and Lower Limb Spasticity Treated With OnabotulinumtoxinA: Insights From the ASPIRE Study
Objective: To assess measures of pain and functional impairment in patients treated with onabotulinumtoxinA (onabotA) who are naive to botulinum toxins with upper limb (UL)…Pain reduction in adult patients with limb spasticity following a single incobotulinumtoxinA injection: an analysis of pooled data from phase 2 and 3 studies
Objective: To assess pain relief in a large cohort of incoA-treated pts with spasticity-associated pain (SAP) using pooled data from mostly placebo-controlled phase 2/3 studies.…Benefit of multiple incobotulinumtoxinA injections for pain reduction in adult patients with limb spasticity: an analysis of pooled data from phase 2 and 3 studies
Objective: To assess pain relief after multiple incoA injections in a large sample of pts with limb spasticity-associated pain (SAP) using pooled data from six…Pooled safety analysis of incobotulinumtoxinA in the treatment of neurological disorders in adults
Objective: To examine the pooled incidence of treatment-emergent adverse events (TEAEs) and immunogenicity by indication in sponsored incobotulinumtoxinA (INCO) clinical trials in adults. Background: The…Choice of shoulder muscles for the multi-pattern treatment of upper limb spasticity with botulinum neurotoxin injections
Objective: To present an experts’ consensus on the use of botulinum neurotoxin (BoNT) injections in the multi-pattern treatment of shoulder spasticity to increase awareness of…Lack of immunogenicity of incobotulinumtoxinA in pediatrics: A pooled analysis
Objective: To present pooled data analyses of the immunogenicity of incobotulinumtoxinA (INCO) in pediatrics. Background: BotulinumtoxinA (BoNT-A) is used to treat several chronic pediatric conditions,…Pain and Disability Outcomes in Hemiparetic Patients With Post-Stroke Spasticity: Exploratory Analysis of the ASPIRE Study
Objective: To assess measures of pain and functional impairment in hemiparetic patients with post-stroke spasticity (PSS) treated with onabotulinumtoxinA (onabotA) from the Adult Spasticity International…
- 1
- 2
- 3
- …
- 6
- Next Page »